Noom's Integrated Weight Loss Platform

This is a bundling strategy, not just a drug strategy. Noom is trying to own the full weekly weight loss workflow, prescription, dose changes, meal logging, activity tracking, and coach check ins, so the member does not need one app for meds and another for behavior change. That matters because GLP-1 access is getting easier to copy, while habit data and ongoing coaching create more reasons to stay inside one product.

• Noom’s core product was already a mix of calorie tracking and coaching. It layered GLP-1 prescribing onto that base, with clinician messaging inside the app and a program built around medication plus behavior change, instead of treating the prescription as a standalone transaction.
  1 sacra 2 sacra 4 noom
• Hims approaches weight loss more like a broad telehealth subscription. It offers branded and compounded GLP-1s, oral kits, provider review, follow ups, and optional meal replacements, but the model is designed to work across many categories, from hair loss to sexual health to mental health, not only obesity.
  5 hims 6 hims
• The closest legacy comparison is WeightWatchers, which built retention around coaching and structured eating plans. Noom modernized that into a mobile app with text based coaching and food tracking, then added medication. That makes it look less like a pure pharmacy and more like a software guided obesity clinic.
  2 sacra 3 sacra 7 weightwatchers

The category is moving toward integrated obesity care, where the winning product pairs prescription access with day to day support that helps members stay on treatment and keep weight off. If GLP-1 supply and pricing keep normalizing, the companies with the strongest closed loop between meds, tracking, and coaching should capture the most durable retention and margin.